Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

349 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The homeodomain-containing proteins: an update on their interacting partners.
Chariot A, Gielen J, Merville MP, Bours V. Chariot A, et al. Among authors: gielen j. Biochem Pharmacol. 1999 Dec 15;58(12):1851-7. doi: 10.1016/s0006-2952(99)00234-8. Biochem Pharmacol. 1999. PMID: 10591139 Review.
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets.
Chariot A, Meuwis MA, Bonif M, Leonardi A, Merville MP, Gielen J, Piette J, Siebenlist U, Bours V. Chariot A, et al. Among authors: gielen j. Curr Med Chem. 2003 Apr;10(7):593-602. doi: 10.2174/0929867033457926. Curr Med Chem. 2003. PMID: 12678791 Review.
Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.
Viatour P, Legrand-Poels S, van Lint C, Warnier M, Merville MP, Gielen J, Piette J, Bours V, Chariot A. Viatour P, et al. Among authors: gielen j. J Biol Chem. 2003 Nov 21;278(47):46541-8. doi: 10.1074/jbc.M306381200. Epub 2003 Sep 12. J Biol Chem. 2003. PMID: 12972430
Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity.
Fillet M, Bentires-Alj M, Deregowski V, Greimers R, Gielen J, Piette J, Bours V, Merville MP. Fillet M, et al. Among authors: gielen j. Biochem Pharmacol. 2003 May 15;65(10):1633-42. doi: 10.1016/s0006-2952(03)00125-4. Biochem Pharmacol. 2003. PMID: 12754099
Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.
Robe PA, Princen F, Martin D, Malgrange B, Stevenaert A, Moonen G, Gielen J, Merville M, Bours V. Robe PA, et al. Among authors: gielen j. Biochem Pharmacol. 2000 Jul 15;60(2):241-9. doi: 10.1016/s0006-2952(00)00315-4. Biochem Pharmacol. 2000. PMID: 10825469
Homeobox genes: potential candidates for the transcriptional control of the transformed and invasive phenotype.
Castronovo V, Kusaka M, Chariot A, Gielen J, Sobel M. Castronovo V, et al. Among authors: gielen j. Biochem Pharmacol. 1994 Jan 13;47(1):137-43. doi: 10.1016/0006-2952(94)90447-2. Biochem Pharmacol. 1994. PMID: 7906121
Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells.
Charlier C, Chariot A, Antoine N, Merville MP, Gielen J, Castronovo V. Charlier C, et al. Among authors: gielen j. Biochem Pharmacol. 1995 Jan 31;49(3):351-8. doi: 10.1016/0006-2952(94)00492-5. Biochem Pharmacol. 1995. PMID: 7857322
CBP and histone deacetylase inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein.
Chariot A, van Lint C, Chapelier M, Gielen J, Merville MP, Bours V. Chariot A, et al. Among authors: gielen j. Oncogene. 1999 Jul 8;18(27):4007-14. doi: 10.1038/sj.onc.1202776. Oncogene. 1999. PMID: 10435624
IkappaB-alpha enhances transactivation by the HOXB7 homeodomain-containing protein.
Chariot A, Princen F, Gielen J, Merville MP, Franzoso G, Brown K, Siebenlist U, Bours V. Chariot A, et al. Among authors: gielen j. J Biol Chem. 1999 Feb 26;274(9):5318-25. doi: 10.1074/jbc.274.9.5318. J Biol Chem. 1999. PMID: 10026139
Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells.
Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V. Dejardin E, et al. Among authors: gielen j. Oncogene. 1999 Apr 22;18(16):2567-77. doi: 10.1038/sj.onc.1202599. Oncogene. 1999. PMID: 10353600
349 results
Jump to page
Feedback